The Implications of Aging Populations on Healthcare: A Comparative Analysis of Japan and China

The global demographic landscape is undergoing significant transformations, with aging populations becoming a prevalent trend across many countries. This article explores the implications of aging populations on healthcare systems, focusing on a comparative analysis between Japan and China. By examining key statistics and healthcare trends, we gain insights into the challenges and opportunities brought about by demographic changes in these two nations.

1. Japan's Aging Population and Healthcare Challenges:
Since 1993, Japan has witnessed a rapid increase in its aging rate, leading to significant challenges in its healthcare system. The share of health costs as a percentage of GDP reached 11.5% in 2022, reflecting the burden of healthcare expenditure. Social security expenditure in GDP also rose from 14.7% in 1995 to 23.4% in 2018, highlighting the strain on public resources.

1.1 Medical Expenditure and Disease Spectrum:
The per capita medical expenditure for individuals aged 65 and above in Japan is substantially higher compared to other age groups. In 2019, it was 4.6 times that of 0-14 years old, 6 times that of 15-44 years old, and 2.6 times that of 45-64 years old. The elderly population accounts for a significant proportion of medical spending for major diseases such as circulatory diseases (80%), cancer (66%), and neurological Alzheimer's disease (98%).

1.2 Chronic Diseases and Top Expenditures:
Chronic diseases are the primary contributors to medical expenses for individuals over 65 years old in Japan. The top ten disease expenses in 2019 included heart disease (excluding hypertension), cerebrovascular disease, hypertension, fracture, mental and behavioral disorders, diabetes, joint diseases, spine diseases, lung cancer, and colorectal cancer.

2. China's Aging Population and Healthcare Outlook:
China is currently experiencing a demographic shift similar to that of Japan in 1993. By 2035, the aging population is projected to surge due to the compensatory birth from 1962 to 1975, leading to increased healthcare demands.

2.1 Health Expenditure and Opportunities:
In 2022, China's total health expenditure accounted for 7.0% of GDP, lower than the average level of developed countries. This suggests potential opportunities for growth and development in the healthcare sector. The increasing prevalence of age-related macular degeneration (AMD) and type 2 diabetes presents areas for investment and innovation.

2.2 Advancements in Medical Treatments:
China is witnessing advancements in medical treatments for age-related macular degeneration (AMD) and type 2 diabetes. Clinical trials for anti-VEGF drugs and GLP-1 hypoglycemic drugs are underway, offering promising prospects for improved patient outcomes. Additionally, the adoption of continuous glucose monitoring (CGM) devices is expected to increase among the aging population, driven by the clinical application of GLP-1 drugs.

3. Rehabilitation Care and Medical Devices:
Rehabilitation care is an essential aspect of addressing the needs of aging populations. Samsung Medical, with its chain mode and verified development scale, has shown significant growth in revenue and net profit. The shortage of rehabilitation beds in China highlights opportunities for expansion and investment in this sector. Medical device companies, such as Xiangyu Medical, have experienced steady revenue and net profit growth, indicating resilience in the market.

The aging populations in Japan and China pose significant challenges and opportunities for their respective healthcare systems. Japan's experience provides valuable lessons on the impact of aging on healthcare expenditure, the prevalence of chronic diseases, and the changing disease spectrum. Meanwhile, China's current demographic transition presents opportunities for improving healthcare infrastructure, advancing medical treatments, and expanding rehabilitation care. By understanding these dynamics, policymakers and stakeholders can better prepare and adapt their healthcare systems to meet the evolving needs of aging populations.